Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hodgkin Disease"" wg kryterium: Temat


Starter badań:

Tytuł :
Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma.
Autorzy :
Qin JQ; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Yin H; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Wu JZ; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Chen RZ; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Xia Y; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Wang L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Zhu HY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Fan L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Li JY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.
Liang JH; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China. Electronic address: .
Xu W; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China. Electronic address: .
Pokaż więcej
Źródło :
Leukemia research [Leuk Res] 2021 Aug; Vol. 107, pp. 106607. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA, Viral*
Viral Load*
Epstein-Barr Virus Infections/*complications
Epstein-Barr Virus Infections/*virology
Herpesvirus 4, Human/*genetics
Hodgkin Disease/*blood
Hodgkin Disease/*mortality
Biomarkers ; Hodgkin Disease/etiology ; Hodgkin Disease/therapy ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
Spinal cord compression as tumor onset: an unusual case report of Hodgkin lymphoma in a teenager.
Autorzy :
Salomone G; Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
La Spina M; Unit of Pediatric Hematology Oncology, Department of Clinical and Experimental Medicine, Hospital Policlinico 'G. Rodolico', University of Catania, Via Santa Sofia 78, Catania, Italy.
Belfiore G; Unit of Radiology, Department Ingrassia, Hospital Policlinico 'G. Rodolico', University of Catania, Catania, Italy.
Bertuna G; Unit of Pediatric Hematology Oncology, Department of Clinical and Experimental Medicine, Hospital Policlinico 'G. Rodolico', University of Catania, Via Santa Sofia 78, Catania, Italy.
Cannavò L; Unit of Pediatrics, Hospital Policlinico 'G. Martino', University of Messina, Messina, Italy.
Catanzaro S; Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
D'Amico S; Unit of Pediatric Hematology Oncology, Department of Clinical and Experimental Medicine, Hospital Policlinico 'G. Rodolico', University of Catania, Via Santa Sofia 78, Catania, Italy.
Meli M; Unit of Pediatric Hematology Oncology, Department of Clinical and Experimental Medicine, Hospital Policlinico 'G. Rodolico', University of Catania, Via Santa Sofia 78, Catania, Italy.
Musumeci A; Unit of Radiology, Department Ingrassia, Hospital Policlinico 'G. Rodolico', University of Catania, Catania, Italy.
Salvatorelli L; Unit of Anatomic Pathology, Department Ingrassia, Hospital Policlinico 'G. Rodolico', University of Catania, Catania, Italy.
Scuderi MG; Unit of Pediatric Surgery, Department Ingrassia, Hospital Policlinico 'G. Rodolico', University of Catania, Catania, Italy.
Spatola C; Unit of Radiotherapy, Department Ingrassia, Hospital Policlinico 'G. Rodolico', University of Catania, Catania, Italy.
Valenzise M; Unit of Pediatrics, Hospital Policlinico 'G. Martino', University of Messina, Messina, Italy.
Di Cataldo A; Unit of Pediatric Hematology Oncology, Department of Clinical and Experimental Medicine, Hospital Policlinico 'G. Rodolico', University of Catania, Via Santa Sofia 78, Catania, Italy.
Russo G; Unit of Pediatric Hematology Oncology, Department of Clinical and Experimental Medicine, Hospital Policlinico 'G. Rodolico', University of Catania, Via Santa Sofia 78, Catania, Italy. .
Pokaż więcej
Źródło :
BMC pediatrics [BMC Pediatr] 2021 Aug 24; Vol. 21 (1), pp. 358. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hodgkin Disease*/complications
Hodgkin Disease*/diagnosis
Premature Birth*
Spinal Cord Compression*/diagnostic imaging
Spinal Cord Compression*/etiology
Adolescent ; Child ; Delayed Diagnosis ; Female ; Humans ; Infant, Newborn ; Pregnancy ; Thoracic Vertebrae/diagnostic imaging
Czasopismo naukowe
Tytuł :
Clinicopathologic features and therapy outcome in childhood Hodgkin's lymphoma: a report from tertiary care center in Saudi Arabia.
Autorzy :
Alkhayat N; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Alshahrani M; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia. .
Elyamany G; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Sedick Q; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Ibrahim W; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Hamzi H; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Binhassan A; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Othman M; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Alshieban S; Department of Pathology and Laboratory Medicine, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Aljabry MS; Pathology Department, King Khalid University Hospital, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Asiri S; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Alzouman M; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Alsuhaibani O; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Alabbas F; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Alsharif O; Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
Elborai Y; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło :
Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2021 Aug 16; Vol. 33 (1), pp. 21. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article
MeSH Terms :
Hodgkin Disease*/diagnosis
Hodgkin Disease*/epidemiology
Hodgkin Disease*/therapy
Adolescent ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bleomycin/therapeutic use ; Child ; Child, Preschool ; Dacarbazine/therapeutic use ; Doxorubicin ; Female ; Humans ; Male ; Neoplasm Recurrence, Local ; Saudi Arabia/epidemiology ; Tertiary Care Centers ; Treatment Outcome ; Vinblastine/therapeutic use
Czasopismo naukowe
Tytuł :
Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients.
Autorzy :
Chander G; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
Dassanayake H; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
Kaparou M; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
Ahmed M; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
Kishore B; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
Nikolousis E; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
Kanellopoulos A; Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K. .; Haematology Department and Bone Marrow Transplantation Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Aug; Vol. 41 (8), pp. 4017-4020.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hodgkin Disease*/diagnostic imaging
Hodgkin Disease*/immunology
Hodgkin Disease*/pathology
Adult ; Aged ; Antigens, CD/immunology ; Female ; Humans ; Immunophenotyping ; Lymphocytes/immunology ; Male ; Middle Aged ; Positron Emission Tomography Computed Tomography
Czasopismo naukowe
Tytuł :
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy.
Autorzy :
Wenge DV; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Wethmar K; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Mikesch JH; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Reicherts C; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Schliemann C; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Mesters R; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Kessler T; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Khandanpour C; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Kerkhoff A; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Schmitz N; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Berdel WE; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Lenz G; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Stelljes M; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 1930-1939. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Hodgkin Disease*/therapy
Disease-Free Survival ; Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Unusual Clinical Presentation of Hodgkin Lymphoma in a Child: Both Spinal Cord Compression and Hydronephrosis.
Autorzy :
Bayram N; Departments of Pediatric Hematology and Oncology.
Yaman Y; Departments of Pediatric Hematology and Oncology.
Elli M; Departments of Pediatric Hematology and Oncology.
Dogan MS; Pediatric Radiology.
Ayyildiz S; Pediatric Surgery.
Telhan L; Pediatric Intensive Care Unit.
Çakir A; Departments of Pathology.
Unal D; Radiation Oncology.
Sebirli F; Pediatrics, Istanbul Medipol University, Istanbul, Turkey.
Anak S; Departments of Pediatric Hematology and Oncology.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Aug 01; Vol. 43 (6), pp. e900-e902.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hodgkin Disease/*complications
Hydronephrosis/*complications
Spinal Cord Compression/*complications
Child ; Diagnosis, Differential ; Hodgkin Disease/diagnosis ; Hodgkin Disease/pathology ; Humans ; Hydronephrosis/diagnosis ; Hydronephrosis/pathology ; Male ; Spinal Cord Compression/diagnosis ; Spinal Cord Compression/pathology
Czasopismo naukowe
Tytuł :
Diagnostic dilemma of Hodgkin's lymphoma versus tuberculosis: a case report and review of the literature.
Autorzy :
Banerjee A; Faculty of Medicine, Imperial College London, London, UK. .
Bhuller K; Haematology, Children's and Adolescent Services, University Hospitals of Leicester NHS Trust, Leicester, UK.
Sudhir R; Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.
Bajaj A; Radiology, University Hospitals of Leicester NHS Trust, Leicester, UK.
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2021 Jul 19; Vol. 15 (1), pp. 351. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Hodgkin Disease*/diagnosis
Hodgkin Disease*/drug therapy
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Adult ; Biopsy ; Delayed Diagnosis ; Female ; Humans ; Young Adult
Czasopismo naukowe
Tytuł :
Paraneoplastic Intrahepatic Cholestasis in Supradiaphragmatic Classical Hodgkin Lymphoma Successfully Treated With Brentuximab Vedotin: A Case Report and Review of the Literature.
Autorzy :
Papakonstantinou I; Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Kosmidou M; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Papathanasiou K; Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Koumpis E; Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Kapsali E; Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Milionis H; Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Vassilakopoulos TP; Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Papoudou-Bai A; Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Hatzimichael E; Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; .
Pokaż więcej
Źródło :
In vivo (Athens, Greece) [In Vivo] 2021 Jul-Aug; Vol. 35 (4), pp. 1951-1957.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Cholestasis, Intrahepatic*
Hodgkin Disease*/complications
Hodgkin Disease*/diagnosis
Hodgkin Disease*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bleomycin ; Brentuximab Vedotin ; Dacarbazine/therapeutic use ; Doxorubicin/therapeutic use ; Humans ; Vinblastine/therapeutic use
Czasopismo naukowe
Tytuł :
Further Lessons Learned From a Child With NF1 and Classical Hodgkin Lymphoma.
Autorzy :
Carter Febres M; Division of Pediatric Hematology Oncology.
Viskochil D; Division of Medical Genetics.
Rampton J; Department of Pediatrics, Division of Radiology, University of Utah-Primary Children's Hospital, Salt Lake City, UT.
Afify Z; Division of Pediatric Hematology Oncology.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Jul 01; Vol. 43 (5), pp. e743-e744.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Hodgkin Disease/*complications
Neurofibromatosis 1/*complications
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Child ; Female ; Hodgkin Disease/diagnosis ; Hodgkin Disease/drug therapy ; Humans ; Neurofibromatosis 1/diagnosis ; Neurofibromatosis 1/drug therapy ; Treatment Outcome
Raport
Tytuł :
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life.
Autorzy :
Eikeland SA; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Smeland KB; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Mols F; Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Fagerli UM; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway.
Bersvendsen HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
Kiserud CE; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Jul; Vol. 60 (7), pp. 911-920. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/adverse effects
Hodgkin Disease*/drug therapy
Hodgkin Disease*/epidemiology
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/epidemiology
Female ; Humans ; Quality of Life ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma.
Autorzy :
Swoboda R; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
Giebel S; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
Knopińska-Posłuszny W; Department of Hematology and Bone Marrow Transplantation, Pomeranian Hospitals, Gdynia, Poland.
Chmielowska E; Oncologic Hospital, Tomaszów Mazowiecki, Poland.; Department of Oncology, Oncology Centre, Bydgoszcz, Poland.
Drozd-Sokołowska J; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
Paszkiewicz-Kozik E; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw branch, Warsaw, Poland.
Kulikowski W; Department of Hematology, Independent Public Health Care Ministry of the Interior of Warmia and Mazury Oncology Center, Olsztyn, Poland.
Taszner M; Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland.
Mendrek W; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
Najda J; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
Czerw T; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
Olszewska-Szopa M; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.
Czyż A; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.
Giza A; Department of Hematology, Jagiellonian University, Krakow, Poland.
Spychałowicz W; Internal Medicine and Oncology Clinic, Silesian Medical University, Katowice, Poland.
Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland.
Szwedyk P; Department of Hematology, Ludwik Rydygier Hospital, Krakow, Poland.
Krzywon A; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Wilk A; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Zaucha JM; Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Jul; Vol. 100 (7), pp. 1755-1767. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hodgkin Disease/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Allografts ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bendamustine Hydrochloride/administration & dosage ; Bendamustine Hydrochloride/adverse effects ; Combined Modality Therapy ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Dexamethasone/administration & dosage ; Dexamethasone/adverse effects ; Drug Evaluation ; Female ; Hematologic Diseases/chemically induced ; Hematopoietic Stem Cell Transplantation ; Hodgkin Disease/radiotherapy ; Hodgkin Disease/therapy ; Humans ; Infections/etiology ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Progression-Free Survival ; Radiotherapy, Adjuvant ; Recurrence ; Retrospective Studies ; Transplantation, Autologous ; Young Adult
Czasopismo naukowe
Tytuł :
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial.
Autorzy :
Herrera AF; City of Hope Medical Center, Duarte, CA.
Burton C; St James's University Hospital, Leeds, United Kingdom.
Radford J; Department of Medical Oncology, University of Manchester, Manchester, United Kingdom.
Miall F; University Hospitals of Leicester National Health Service (NHS) Trust, Leicester, United Kingdom.
Townsend W; National Institute for Health Research (NIHR)/University College London Hospitals (UCLH) Clinical Research Facility, UCLH NHS Foundation Trust, London, United Kingdom.
Santoro A; Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Zinzani PL; Institute of Hematology 'L. e A. Seràgnoli', University of Bologna, Bologna, Italy.
Lewis D; University Hospital Plymouth NHS Trust, Plymouth, United Kingdom.
Fowst C; Pfizer Srl, Milan, Italy.
Brar S; Pfizer Oncology, La Jolla, CA.
Huang B; Pfizer Inc, Groton, CT; and.
Thall A; Pfizer Oncology, La Jolla, CA.
Collins GP; Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom.
Pokaż więcej
Źródło :
Blood advances [Blood Adv] 2021 Sep 14; Vol. 5 (17), pp. 3387-3396.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hodgkin Disease*/drug therapy
Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Autorzy :
Goyal A; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
O'Leary D; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.
Goyal K; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.
Rubin N; Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Janakiram M; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.
Pokaż więcej
Źródło :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Sep; Vol. 35 (9), pp. 1821-1829. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Hodgkin Disease*
Lung Neoplasms*/diagnosis
Lung Neoplasms*/epidemiology
Lymphoma, Non-Hodgkin*/complications
Lymphoma, Non-Hodgkin*/diagnosis
Lymphoma, Non-Hodgkin*/epidemiology
Melanoma*/complications
Melanoma*/diagnosis
Melanoma*/epidemiology
Mycosis Fungoides*/complications
Mycosis Fungoides*/diagnosis
Mycosis Fungoides*/epidemiology
Neoplasms, Second Primary*/diagnosis
Neoplasms, Second Primary*/epidemiology
Skin Neoplasms*/complications
Skin Neoplasms*/diagnosis
Skin Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/epidemiology
Aged ; Early Detection of Cancer ; Female ; Humans ; Lung ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Autorzy :
Lynch RC; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Cassaday RD; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Smith SD; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Fromm JR; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Cowan AJ; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Warren EH; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Shadman MS; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Shustov A; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Till BG; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ujjani CS; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Libby EN 3rd; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Philip M; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Coye H; Seattle Cancer Care Alliance, Seattle, WA, USA.
Martino CN; Seattle Cancer Care Alliance, Seattle, WA, USA.
Bhark SL; Seattle Cancer Care Alliance, Seattle, WA, USA.
Morris K; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Rasmussen H; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Behnia S; Department of Radiology, University of Washington, Seattle, WA, USA.
Voutsinas J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gopal AK; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Haematology [Lancet Haematol] 2021 Aug; Vol. 8 (8), pp. e562-e571.
Typ publikacji :
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms :
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Drug Resistance, Neoplasm/*drug effects
Hodgkin Disease/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Adult ; Brentuximab Vedotin/administration & dosage ; Carboplatin/administration & dosage ; Etoposide/administration & dosage ; Female ; Follow-Up Studies ; Hodgkin Disease/pathology ; Humans ; Ifosfamide/administration & dosage ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Survival Rate
Czasopismo naukowe
Tytuł :
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma.
Autorzy :
Paydas S; Cukurova University, Faculty of Medicine, Dept of Oncology, Turkey; Cukurova University, Faculty of Medicine, Dept of Hematology, Turkey. Electronic address: .
Lacin S; Hacettepe University, Faculty of Medicine, Dept of Oncology, Turkey.
Dogan M; Ankara Numune Hospital, Dept of Oncology, Turkey.
Barista I; Hacettepe University, Faculty of Medicine, Dept of Oncology, Turkey.
Yildiz B; Gulhane Hospital, Dept of Oncology, Turkey.
Seydaoglu G; Cukurova University, Faculty of Medicine, Dept of Biostatistics, Turkey.
Karadurmus N; Gulhane Hospital, Dept of Oncology, Turkey.
Civriz S; Ankara University, Faculty of Medicine, Dept of Hematology, Turkey.
Kaplan MA; Dicle University, Faculty of Medicine, Dept of Oncology, Turkey.
Yagci M; Gazi University, Faculty of Medicine, Dept of Hematology, Turkey.
Dincyurek HD; Cukurova University, Faculty of Medicine, Dept of Hematology, Turkey.
Ercolak V; Cukurova University, Faculty of Medicine, Dept of Oncology, Turkey.
Pokaż więcej
Źródło :
Leukemia research [Leuk Res] 2021 Aug; Vol. 107, pp. 106586. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article
MeSH Terms :
Leukocyte Count*
Leukocytes*
Lymphocytes*
Nutritional Status*
Hodgkin Disease/*epidemiology
Biomarkers ; Hodgkin Disease/mortality ; Humans ; Lymphocyte Count ; Prognosis
Czasopismo naukowe
Tytuł :
Future directions in Hodgkin lymphoma: checkpoint inhibitors and beyond.
Autorzy :
Desai S; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 1795-1804. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hodgkin Disease*/drug therapy
Immunoconjugates*
Antibodies, Monoclonal, Humanized ; Humans ; Ki-1 Antigen ; Neoplasm Recurrence, Local ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of F-FDG PET/CT in elderly Hodgkin lymphoma patients: a two-centre validation.
Autorzy :
Albano D; Nuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy.
Camoni L; Nuclear Medicine, ASST Spedali Civili Brescia, Brescia, Italy.
Rinaldi R; Nuclear Medicine, ASST Spedali Civili Brescia, Brescia, Italy.
Tucci A; Hematology Division, ASST Spedali Civili Brescia, Brescia, Italy.
Zilioli VR; Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Muzi C; Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Ravanelli M; Department of Radiology, University of Brescia, Brescia, Italy.
Farina D; Department of Radiology, University of Brescia, Brescia, Italy.
Coppola A; Department of Radiology, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Camalori M; Department of Radiology, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Giubbini R; Nuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy.
Bertagna F; Nuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 Jul 01; Vol. 94 (1123), pp. 20200672. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Tomography, X-Ray Computed*
Adipose Tissue/*diagnostic imaging
Hodgkin Disease/*diagnostic imaging
Muscle, Skeletal/*diagnostic imaging
Sarcopenia/*diagnostic imaging
Aged ; Aged, 80 and over ; Female ; Fluorodeoxyglucose F18 ; Hodgkin Disease/pathology ; Humans ; Male ; Neoplasm Staging ; Radiographic Image Interpretation, Computer-Assisted ; Radiopharmaceuticals ; Retrospective Studies ; Software
Czasopismo naukowe
Tytuł :
Classic Hodgkin lymphoma in Guatemalan children of age less than six years: analysis of immune regulatory pathways and the tumor microenvironment.
Autorzy :
Silva O; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Charu V; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Ewalt MD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Metcalf RA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Zhao S; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Castellanos EM; Unidad Nacional de Oncologia Pediátrica, Guatemala City, Guatemala.
Orellana E; Unidad Nacional de Oncologia Pediátrica, Guatemala City, Guatemala.; School of Medicine, Francisco Marroquin University, Guatemala City, Guatemala.
Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Luna-Fineman S; Pediatric Hematology/Oncology/SCT, Center for Global Health, School of Medicine, University of Colorado Anschutz, Aurora, CO, USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1609-1618. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Journal Article
MeSH Terms :
Epstein-Barr Virus Infections*/complications
Epstein-Barr Virus Infections*/epidemiology
Hodgkin Disease*/epidemiology
Adolescent ; Adult ; Child ; Child, Preschool ; Herpesvirus 4, Human ; Humans ; Infant ; Infant, Newborn ; Neoplasm Recurrence, Local ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Sarcoma-like appearance but pathologic Hodgkin lymphoma.
Autorzy :
Harada S; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Ando J; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.; Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Ando M; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. .
Azusawa Y; Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Ochiai T; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Hashimoto Y; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Hirasawa Y; Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Komatsu N; Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Jul; Vol. 114 (1), pp. 1-2. Date of Electronic Publication: 2021 May 31.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Hodgkin Disease/*diagnosis
Sarcoma/*diagnosis
Adult ; Biopsy ; Bone Marrow/pathology ; Female ; Hodgkin Disease/blood ; Humans ; Sarcoma/blood
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies